When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PTI - Proteostasis down 34% on mixed results in mid-stage CF study
Yumanity Therapeutics Inc Com
Proteostasis Therapeutics (NASDAQ:PTI) slumps 34% premarket on robust volume on the heels of topline results from a Phase 2 clinical trial evaluating its CFTR modulator combinations in cystic fibrosis (CF) patients.
More news on: Proteostasis Therapeutics, Inc., Healthcare stocks news, Stocks on the move,